Kinase activity of mutant LRRK2 mediates neuronal toxicity

Wanli W Smith1, Zhong Pei, Haibing Jiang

  • 1Department of Psychiatry, Division of Neurobiology, Johns Hopkins University School of Medicine, CMSC 8-121, 600 North Wolfe Street, Baltimore, Maryland 21287, USA. wsmith60@jhmi.edu

Nature Neuroscience
|September 19, 2006
PubMed

Insights

Mutations in leucine-rich repeat kinase-2 (LRRK2) cause Parkinson disease. Reduced LRRK2 kinase activity lessened neuronal toxicity, suggesting new therapeutic targets for Parkinson disease.

Area of Science:

  • Neuroscience
  • Genetics
  • Biochemistry

Background:

  • Mutations in the leucine-rich repeat kinase-2 (LRRK2) gene are linked to autosomal-dominant and some sporadic forms of Parkinson disease.
  • Understanding the molecular mechanisms underlying LRRK2's role in Parkinson disease pathogenesis is crucial for developing effective treatments.

Purpose of the Study:

  • To investigate the regulatory mechanisms of LRRK2 kinase activity.
  • To determine the relationship between LRRK2 kinase activity and neuronal toxicity in Parkinson disease models.

Main Methods:

  • Biochemical assays to study LRRK2 kinase activity regulation.
  • Analysis of LRRK2 protein alterations and their impact on neuronal toxicity.

Main Results:

  • LRRK2 kinase activity is regulated by GTP through its intrinsic GTPase Roc domain.
  • Modifications to LRRK2 that decrease its kinase activity also reduce neuronal toxicity associated with mutant LRRK2.

Conclusions:

  • The GTPase activity of the LRRK2 Roc domain is a key regulator of its kinase function.
  • Reducing LRRK2 kinase activity represents a potential therapeutic strategy for LRRK2-linked Parkinson disease.
  • These findings may also shed light on the mechanisms of sporadic Parkinson disease.

Related Concept Videos

Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...